With people of minority background and those with obesity and diabetes most at risk for severe cases of COVID-19, the National Institute of Diabetes and Digestive and Kidney Diseases is leading in the research behind why that is. Director Dr. Griffin Rodgers, who contributed to the first effective therapy for sickle cell anemia, updates HealthCast on the institute’s work to lessen the effects of COVID-19 on its research community, as well as other top research and data initiatives at the institution.
HealthCast
Season 2
Episode 17
21m listen
How One NIH Institute is Combating COVID-19 and Health Disparities
Share
NIDDK Director Dr. Griffin Rodgers talks COVID-19, disparities in health, and top priorities at the institute.
-
Dr. Griffin Rodgers Director NIDDK
Related Content
-
Wellness Tips for Cyber Leaders at Home
Avni Desai is a dedicated professional at CGI, where she brings a thoughtful blend of leadership, strategic insight and a people‑centered approach to her work.
46m watch -
How Scientists Are Using AI to Analyze the Universe
AstroAI uses AI to identify unexpected patterns in astronomical data, helping scientists uncover new space phenomena.
13m watch -
AI Drives Federal Efficiency Gains but Magnifies Existing Challenges
AI is accelerating research and predictive analytics, but agencies must modernize systems to fully realize the benefits.
3m read -
Inside Federal Acquisition and the Future of Cloud Buying
GSA’s Jonathan Plante discusses how federal cloud acquisition is shifting toward consolidation, transparency, cybersecurity and modernization.
9m watch
